Egenesis

Developer of human-compatible engineered organs and cells designed to address the global shortage of transplantable organs. The company offers a genome-engineering platform that inactivates porcine re...

Healthcare

Cambridge, MA, United States

Founded 2015

135 employees

Website

Valuation

$330M

Market implied

Share Price

N/A

Total Raised

$454M

Last Round

N/A

Investors

+37 other investors

View all 37 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Egenesis's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required